Author | Mirat Shah, MD


CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?

May 15, 2018

ByMirat Shah, MD|Maria Raquel Nunes, MD|Vered Stearns, MD

Here, we review the current use of and potential next directions for CDK4/6 inhibitors in the treatment of patients with HR-positive breast cancer.